Under Armour Cuts FY26 Revenue Outlook; Stock Slides

What happened

Under Armour shares fell this week after the company reported quarterly results that missed expectations and lowered its full-year revenue guidance, extending the stock's steep decline from recent highs. The cut follows the fiscal Q3 2026 (December quarter) already showing revenue down 5% year over year and gross margin down 310 basis points to 44.4%, with management citing tariffs and a more promotional North America environment. Combined with the restructuring program still running up to $255 million, the latest guidance reduction signals that demand stabilization is further out than the market had priced, contradicting the earlier 'less-bad' narrative from February 2026. Liquidity remains adequate with $465 million cash and restricted investments pre-funding the June 2026 maturity, but that does not offset the erosion in pricing power and brand health. The stock now trades below the prior 'attractive entry' of $5.75, and the base-case implied value of $7.25 looks increasingly optimistic without concrete margin recovery.

Implication

The lowered full-year revenue guidance confirms that the FY26 reset is not progressing as quickly as management suggested in early 2026, reducing confidence in the base-case stabilization scenario. With gross margin still near 44% and North America likely still declining around 10%, the bear case of $5.00 per share remains more probable than the previous 30% assignment; the bull case of $8.75 is now distant. The company's balance sheet flexibility prevents a liquidity crisis, but the persistent promotional environment and elevated restructuring costs will continue to suppress earnings quality and keep the valuation multiple compressed. Investors should monitor the next two quarterly reports for any sequential gross margin recovery and a slowdown in restructuring charges; failure to show improvement would justify a move toward the bear-case valuation. Given the stock's recent drop, risk-reward has improved somewhat, but the fundamental signals required for a re-rating are still absent; patience and a strict checkpoint discipline are warranted.

Thesis delta

The thesis shifts from 'stabilization priced in' to 'stabilization delayed' as the company lowers full-year revenue guidance, undermining the earlier belief that the worst quarter was behind it. The previous WAIT rating with a $5.75 attractive entry is now being tested; the stock may have moved below that level, but the confirmation signals (gross margin >45.5%, North America better than -6%) are still required before any upgrade. Consequently, the probability of the bear scenario increases from 30% to closer to 40%, and the base-case implied value of $7.25 should be trimmed toward $6.75 or lower pending further evidence.